{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Bombésine : Questions médicales les plus fréquentes",
"headline": "Bombésine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Bombésine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-22",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Bombésine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Venins d'amphibien",
"url": "https://questionsmedicales.fr/mesh/D000664",
"about": {
"@type": "MedicalCondition",
"name": "Venins d'amphibien",
"code": {
"@type": "MedicalCode",
"code": "D000664",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.833.033"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Bombésine",
"alternateName": "Bombesin",
"code": {
"@type": "MedicalCode",
"code": "D001839",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xiaoqun Qin",
"url": "https://questionsmedicales.fr/author/Xiaoqun%20Qin",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, Hunan, PR China."
}
},
{
"@type": "Person",
"name": "Xiangping Qu",
"url": "https://questionsmedicales.fr/author/Xiangping%20Qu",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Hui Wang",
"url": "https://questionsmedicales.fr/author/Hui%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, School of Basic Medical Science, Central South University, Changsha, China."
}
},
{
"@type": "Person",
"name": "Jiaoyun Zheng",
"url": "https://questionsmedicales.fr/author/Jiaoyun%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China."
}
},
{
"@type": "Person",
"name": "Jie Wang",
"url": "https://questionsmedicales.fr/author/Jie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, School of Basic Medical Science, Central South University, Changsha, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Diagnostic accuracy of a set of clinical and radiological criteria for screening of COVID-19 using RT-PCR as the reference standard.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36894945",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12890-023-02369-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36038643",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03647-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The diagnostic value of dual-layer CT in the assessment of lymph nodes in lymphoma patients with PET/CT as a reference standard.",
"datePublished": "2023-10-26",
"url": "https://questionsmedicales.fr/article/37884597",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-45198-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Towards standardization of measuring anxiety and depression: Differential item functioning for language and Dutch reference values of PROMIS item banks.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998333",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0273287"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.",
"datePublished": "2023-01-03",
"url": "https://questionsmedicales.fr/article/36594836",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1148/radiol.220984"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Venins",
"item": "https://questionsmedicales.fr/mesh/D014688"
},
{
"@type": "ListItem",
"position": 5,
"name": "Venins d'amphibien",
"item": "https://questionsmedicales.fr/mesh/D000664"
},
{
"@type": "ListItem",
"position": 6,
"name": "Bombésine",
"item": "https://questionsmedicales.fr/mesh/D001839"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Bombésine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Bombésine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Bombésine",
"description": "Comment diagnostiquer une surproduction de bombésine ?\nQuels examens sont utilisés pour évaluer la fonction de la bombésine ?\nQuels symptômes peuvent indiquer un excès de bombésine ?\nLa biopsie est-elle nécessaire pour diagnostiquer des tumeurs liées à la bombésine ?\nQuels marqueurs tumoraux sont associés à la bombésine ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Bombésine",
"description": "Quels sont les symptômes d'une tumeur sécrétant de la bombésine ?\nLa bombésine peut-elle causer des troubles de l'appétit ?\nY a-t-il des symptômes neurologiques liés à la bombésine ?\nComment la bombésine affecte-t-elle la digestion ?\nLes symptômes de la bombésine sont-ils similaires à ceux d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Bombésine",
"description": "Peut-on prévenir les tumeurs liées à la bombésine ?\nLes dépistages réguliers peuvent-ils aider à détecter des problèmes liés à la bombésine ?\nY a-t-il des facteurs de risque à surveiller pour la bombésine ?\nUne alimentation équilibrée peut-elle réduire le risque de tumeurs à bombésine ?\nLe tabagisme influence-t-il le risque de tumeurs à bombésine ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Bombésine",
"description": "Quels traitements sont disponibles pour les tumeurs à bombésine ?\nLa thérapie ciblée est-elle efficace contre les tumeurs sécrétant de la bombésine ?\nDes médicaments peuvent-ils bloquer l'effet de la bombésine ?\nLa radiothérapie est-elle une option pour les tumeurs à bombésine ?\nQuels sont les effets secondaires des traitements contre la bombésine ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Bombésine",
"description": "Quelles complications peuvent survenir avec des tumeurs à bombésine ?\nLes tumeurs à bombésine peuvent-elles causer des douleurs chroniques ?\nComment les complications des tumeurs à bombésine sont-elles gérées ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il des complications liées aux traitements des tumeurs à bombésine ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Bombésine",
"description": "Quels sont les principaux facteurs de risque pour les tumeurs à bombésine ?\nL'âge est-il un facteur de risque pour les tumeurs à bombésine ?\nLes maladies gastro-intestinales augmentent-elles le risque de bombésine ?\nLe stress a-t-il un impact sur le risque de bombésine ?\nUne exposition à des toxines peut-elle augmenter le risque de bombésine ?",
"url": "https://questionsmedicales.fr/mesh/D001839?mesh_terms=Reference+Standards&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une surproduction de bombésine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des imageries peuvent aider à détecter des niveaux élevés de bombésine."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer la fonction de la bombésine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie et l'IRM peuvent être utilisés pour évaluer les tumeurs sécrétant de la bombésine."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un excès de bombésine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales et des troubles digestifs peuvent indiquer un excès."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle nécessaire pour diagnostiquer des tumeurs liées à la bombésine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie peut être nécessaire pour confirmer la présence de tumeurs sécrétant de la bombésine."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés à la bombésine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme le CEA et le CA 19-9 peuvent être associés à des tumeurs sécrétant de la bombésine."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une tumeur sécrétant de la bombésine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, diarrhée, et nausées fréquentes."
}
},
{
"@type": "Question",
"name": "La bombésine peut-elle causer des troubles de l'appétit ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surproduction de bombésine peut entraîner des modifications de l'appétit."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques liés à la bombésine ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des maux de tête peuvent survenir en cas d'excès."
}
},
{
"@type": "Question",
"name": "Comment la bombésine affecte-t-elle la digestion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut augmenter la motilité intestinale, provoquant des diarrhées ou des crampes."
}
},
{
"@type": "Question",
"name": "Les symptômes de la bombésine sont-ils similaires à ceux d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux d'autres troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs liées à la bombésine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain peut aider."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers peuvent-ils aider à détecter des problèmes liés à la bombésine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent aider à détecter des anomalies précoces."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque à surveiller pour la bombésine ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer et des maladies gastro-intestinales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée peut-elle réduire le risque de tumeurs à bombésine ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut contribuer à réduire le risque de divers cancers."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque de tumeurs à bombésine ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs types de cancers."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les tumeurs à bombésine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La thérapie ciblée est-elle efficace contre les tumeurs sécrétant de la bombésine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines thérapies ciblées peuvent être efficaces pour traiter ces tumeurs."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils bloquer l'effet de la bombésine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antagonistes des récepteurs de la bombésine peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option pour les tumeurs à bombésine ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour réduire la taille des tumeurs."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements contre la bombésine ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, nausées et troubles sanguins."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des tumeurs à bombésine ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la métastase, l'obstruction intestinale et des saignements."
}
},
{
"@type": "Question",
"name": "Les tumeurs à bombésine peuvent-elles causer des douleurs chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des douleurs chroniques en raison de leur localisation."
}
},
{
"@type": "Question",
"name": "Comment les complications des tumeurs à bombésine sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont gérées par des traitements symptomatiques et des interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications liées aux traitements des tumeurs à bombésine ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires et des complications additionnelles."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les tumeurs à bombésine ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'obésité et le tabagisme sont des facteurs de risque importants."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les tumeurs à bombésine ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Les maladies gastro-intestinales augmentent-elles le risque de bombésine ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies gastro-intestinales peuvent augmenter le risque de tumeurs à bombésine."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le risque de bombésine ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer le risque de développer des troubles liés à la bombésine."
}
},
{
"@type": "Question",
"name": "Une exposition à des toxines peut-elle augmenter le risque de bombésine ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut être un facteur de risque."
}
}
]
}
]
}
The gold-standard method for establishing a microbiological diagnosis of COVID-19 is reverse-transcriptase polymerase chain reaction (RT-PCR). This study aimed to evaluate the accuracy, sensitivity, s...
Diagnostic accuracy study including a historical cohort of 1009 patients consecutively admitted to ICUs across six hospitals in Curitiba (Brazil) from March to September, 2020. The sample was stratifi...
With respect to RT-PCR, the proposed criteria had 98.5% (95% confidence interval [95% CI] 97.5-99.5%) sensitivity, 70% (95% CI 65.8-74.2%) specificity, 85.5% (95% CI 83.4-87.7%) accuracy, PPV of 79.7%...
The proposed set of clinical-radiological criteria were accurate in identifying patients with strong versus weak suspicion for COVID-19 and had high sensitivity and considerable specificity with respe...
To compare the diagnostic performance of T1 mapping and MR elastography (MRE) for staging of hepatic fibrosis and grading inflammation with histopathology as standard of reference....
68 patients with various liver diseases undergoing liver biopsy for suspected fibrosis or with an established diagnosis of cirrhosis prospectively underwent look-locker inversion recovery T1 mapping a...
Histopathological analysis diagnosed 9 patients with F0 (13.2%), 21 with F1 (30.9%), 11 with F2 (16.2%), 10 with F3 (14.7%), and 17 with F4 (25.0%). Both T1 mapping and MRE showed significantly higher...
T1 mapping is able to diagnose hepatic fibrosis, however, with a tendency toward lower diagnostic performance compared to MRE and thus may be used as an alternative to MRE for diagnosing hepatic fibro...
This study aimed to evaluate the diagnostic performances of dual-layer CT (DLCT) for the identification of positive lymph nodes (LNs) in patients with lymphoma and retrospectively included 1165 LNs ob...
The outcomes anxiety and depression are measured frequently by healthcare providers to assess the impact of a disease, but with numerous instruments. PROMIS item banks provide an opportunity for stand...
PROMIS Anxiety and Depression item banks were completed by 1002 representative Dutch persons. To evaluate cross-cultural validity, data from US participants in PROMIS wave 1 were used and differential...
In both item banks, two items had DIF but with minimal impact on population level T-scores for full item banks and short forms. The Dutch general population had a T-score of 49.9 for anxiety and 49.6 ...
The limited number of items with DIF and its minimal impact, enables the use of standard (US) item parameters and comparisons of scores between Dutch and US populations. The Dutch reference values pro...
Background Breast cancer tumors can be identified as different luminal molecular subtypes depending on either immunohistochemical (IHC) staining or St Gallen criteria that includes Ki-67. Purpose To c...
Functional dyspepsia (FD) is diagnosed based on self-reported symptoms and negative upper gastrointestinal endoscopic findings. The Rome criteria were not adopted as a diagnostic instrument in clinica...
A total of 220 dyspeptic patients sampled consecutively from a tertiary hospital and the community completed the Rome IV diagnostic questionnaire, which was translated into Cantonese-Chinese, and the ...
Among the participants, 160 (72.7%) fulfilled the Reference Standard with negative upper gastrointestinal endoscopic results. The Reference Standard identified patients with Rome IV-defined FD with 91...
The Reference Standard can rule out patients without Rome IV-defined FD. It may be used as an initial screening tool for FD in settings where the use of the Rome IV criteria is impractical. It may als...
Estimation of prevalence and diagnostic test accuracy in tuberculosis (TB) prevalence surveys suffer from reference standard and verification biases. The former is attributed to the imperfect referenc...
We performed a secondary analysis of 9869 participants aged ≥15 years from a community-based multimorbidity screening study in a rural district of KwaZulu-Natal, South Africa (Vukuzazi study). Partici...
Based on simulation, Bayesian LCA with simultaneous imputation of the missing bacteriological test results under the assumption that the missing data are MAR and MNAR alleviate the reference standard ...
The findings demonstrate the efficacy of these advanced techniques in alleviating the reference standard and verification biases, enhancing the robustness of community-based screening programs. Imputi...
In this study, we aimed to determine the feasibility of transferring IGF-1 reference intervals between two liquid chromatography-mass spectrometry assays with distinct assay formats and calibration tr...
To adopt a reference interval (RI) for our new assay we have conducted RI transference and verification studies according to the CLSI EP28-A3c and EP9c guidelines. Specifically, the analytical agreeme...
Our study showed a strong correlation (R...
Taken together, this study provides data to suggest excellent agreement between assays traceable to distinct reference standards for IGF-1....
Conventional MR pulse sequences result in poor signal from low T2 cortical bone because the minimum achievable echo time is limited. A sequence resulting in improved bone contrast is desirable....
To evaluate the image quality and diagnostic performance of grayscale inversion zero echo time imaging (GI-ZTE) and grayscale inversion T1-weighted imaging (GI-T1WI) compared with computed tomography ...
Prospective....
A total of 50 patients with musculoskeletal tumors or tumor-like diseases of the lower extremities having MRI and CT studies....
GI-T1WI and GI-ZTE sequences at 1.5 T....
Assessed cortical and medullary bone morphology abnormalities using CT as the reference standard. Three radiologists scored the images quality and recorded nine metrics to assess the diagnostic perfor...
Differences in image quality were calculated using the Wilcoxon signed-rank test. The intraclass correlation coefficient (ICC) was used to analyze the agreement of quantitative lesion parameters betwe...
Image quality score was significantly higher for CT images than GI-TIWI images. Except for radiologist 3 [4(0) vs 4 (1)], there was no significant difference in scores between CT and GI-ZTE [radiologi...
GI-ZTE images had superior intermodality agreement with CT images and allowed visualization of more cortical bone detail than GI-T1WI images....
1....
Stage 2....
Treatment of methamphetamine dependence requires monitoring of recent use or abstinence. Self-report is commonly used for routine monitoring, but the accuracy of self-report is not established. For th...
This study was a secondary (subgroup) analysis from a randomized controlled pharmacotherapy trial. Three Australian outpatient addiction services took part. Particpants were 139 people dependent on me...
Weekly oral fluid samples over 12 weeks to determine methamphetamine (and amphetamine) concentrations were used as the reference standard. Self-report of any methamphetamine use in the previous 7 days...
Sensitivity was 96.4% [95% confidence interval (CI) = 95-97.5], specificity was 63.7% (95% CI = 57.3-69.8) and positive predictive value (PPV) was 90.8% (95% CI = 88.8-92.6). The unadjusted NPV was 82...
Self-report of no recent methamphetamine use appears to be sufficiently accurate to be clinically useful at the expected prevalence rates of methamphetamine use in clinical treatment settings. If gene...